so subgroup analysis for gilead breast cancer drug
Post# of 145873
subgroup analysis of cytodyn covid paitents during an emergency that had 78% and 84% SURVIVAL RATES over placebo + standard treatment = not ok and downright obnoxious to even consider subgroups
got it.
so glad the FDA is our guardian. i feel so safe now.
when will these pastey clowns get challenged? why is their power so absolute?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)